Blog
Ocugen Eyes 3 Retinal Gene Therapy Filings as Late-Stage Pipeline Advances
Key Points
- Interested in Ocugen, Inc.? Here are five stocks we like better.
- Ocugen plans three late-stage retinal gene therapy filings, targeting BLAs for retinitis pigmentosa and Stargardt
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day
Key Points
- Interested in Nyxoah SA? Here are five stocks we like better.
- Nyxoah said its U.S. Genio launch is gaining traction, citing 262 trained surgeons, 123 ordering customers, and 427
Netskope Shareholders Reelect Directors, Ratify KPMG at Annual Meeting
Key Points
- Interested in Netskope Inc.? Here are five stocks we like better.
- Netskope shareholders approved both proposals at the company’s virtual annual meeting on July 7, 2026, according to
MicroVision Shareholders Clear Reverse Split Plan, Convertible Note Share Issuance
Key Points
- Interested in Microvision, Inc.? Here are five stocks we like better.
- MicroVision shareholders approved all five proposals at the 2026 annual meeting, including the election of all
Satellos Bioscience DMD Drug Shows Early Promise in 6-Month Study Update
Key Points
- Interested in Satellos Bioscience Inc.? Here are five stocks we like better.
- Satellos Bioscience said its SAT-3247 showed encouraging early signs in a six-month update from the
Seres Therapeutics’ SER-155 Posts 80% Response in Cancer Immunotherapy GI Toxicity Study
Key Points
- Interested in Seres Therapeutics, Inc.? Here are five stocks we like better.
- SER-155 showed an 80% response rate in a Phase 1b study of immune checkpoint inhibitor-related
Information Services Group Sees AI Cloud Demand Fuel Record Tech Spending
Key Points
- Interested in Information Services Group, Inc.? Here are five stocks we like better.
- ISG reported record tech spending in the second quarter, with combined managed services and
Delta Air Lines Q2 Earnings Call Highlights
Key Points
- Interested in Delta Air Lines, Inc.? Here are five stocks we like better.
- Delta posted a strong Q2, with record June-quarter revenue of $17.7 billion, earnings of $1.56 per share
AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
Key Points
- Interested in AeroVironment, Inc.? Here are five stocks we like better.
- AeroVironment’s fiscal 2030 targets triggered analyst concern about execution risk, even as management pointed
Micron's $250 Billion Bet Could Reshape the AI Memory Race
Key Points
- Interested in Micron Technology, Inc.? Here are five stocks we like better.
- Micron Technology accelerated its $250 billion domestic fabrication buildout, including a 10-year silicon
Rocket Lab’s Stock Drop Comes With a Bullish Twist
Key Points
- Interested in Rocket Lab Corporation? Here are five stocks we like better.
- Rocket Lab stock has dropped nearly 45% from its May peak, yet the company just completed a record-fast Space
Forte Biosciences' FB102 Hits Key Goal in Vitiligo Study, Shows Durable Improvement
Key Points
- Interested in Forte Biosciences, Inc.? Here are five stocks we like better.
- Forte Biosciences said FB102 met its primary endpoint in a small placebo-controlled vitiligo study
MTY Food Group Q2 Earnings Call Highlights
Key Points
- Interested in MTY Food Group Inc.? Here are five stocks we like better.
- MTY Food Group’s second-quarter results weakened as softer consumer traffic, inflation in food costs and
Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Key Points
- Interested in Amazon.com, Inc.? Here are five stocks we like better.
- Amazon is using low-cost debt to help fund a massive artificial intelligence infrastructure buildout.
- Investors are
Broadcom's $30 Billion Apple Deal: This Chip Giant Is About More than Just AI
Key Points
- Interested in Broadcom Inc.? Here are five stocks we like better.
- Broadcom extended its chip supply agreement with Apple through 2031, a deal Apple expects to exceed $30 billion in
eToro Group Unveils AI Trading Push With Tori Agent, New App and Desktop Platform
Key Points
- Interested in eToro Group Ltd.? Here are five stocks we like better.
- eToro unveiled a major AI-driven product overhaul, including a rebuilt mobile app, an expanded AI agent named
Velan Q1 Earnings Call Highlights
Key Points
- Interested in Velan Inc.? Here are five stocks we like better.
- Velan’s Q1 results weakened as bookings fell to $48.0 million from $78.2 million and sales dropped to $57.8 million
IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave
Key Points
- Interested in D-Wave Quantum Inc.? Here are five stocks we like better.
- IQM Quantum Computers began trading on Nasdaq in early July, becoming the first European quantum computing firm
Buyer Beware: These 2 Stocks Charts Just Displayed a Death Cross
Key Points
- Interested in Hertz Global Holdings, Inc.? Here are five stocks we like better.
- Both Hertz Global Holdings and Kinross Gold recently formed death cross patterns, a bearish technical
Esperion Therapeutics Clears Key Hurdle as Stockholders Approve Essence Merger
Key Points
- Interested in Esperion Therapeutics, Inc.? Here are five stocks we like better.
- Esperion Therapeutics stockholders approved the company’s merger agreement with Essence Parent and
PepsiCo’s Dividend Could Turn Patience Into Real Profit
Key Points
- Interested in PepsiCo, Inc.? Here are five stocks we like better.
- PepsiCo’s Q2 report was mixed, but not weak enough to break the long-term thesis: revenue beat expectations, organic
DeFi Development Doubles Down on Solana Strategy as Crypto Volatility Spurs Cost Cuts
Key Points
- Interested in DeFi Development Corp.? Here are five stocks we like better.
- DeFi Development is tightening costs and shifting more legal and accounting work in-house after a volatile
Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger
Key Points
- Interested in Catalyst Pharmaceuticals, Inc.? Here are five stocks we like better.
- Catalyst Pharmaceuticals stockholders approved the company’s merger with Angelini Pharma at a
Hays Q4 Earnings Call Highlights
Key Points
- Interested in Hays plc? Here are five stocks we like better.
- Hays reported a 5% like-for-like decline in quarterly net fees, but cost cuts and productivity gains led management to
Schroder Real Estate Invest H2 Earnings Call Highlights
Key Points
- Interested in Schroder Real Estate Invest? Here are five stocks we like better.
- Schroder Real Estate Invest said it remains positioned for earnings growth despite a slight annual